I'll leave it up to you to question the experts on that. The recommendation to me was that those are considered to be low risk. The pharmaceutical industry and the pharmaceutical and prescription products are what this law applies to. Again, I'll leave it up to the committee to ask those questions further and probe on that issue.
On June 5th, 2014. See this statement in context.